This September 5-6, leading experts from across the microbiome therapeutics field will be gathering in Boston to explore the latest developments in accelerating the route from discovery to commercial success for human microbiome therapies.
Our Microbiome Therapeutics US meeting delves into the latest clinical trials, manufacturing and scale-up challenges, and commercialization strategies to take these products to market.
Join the likes of Flagship Pioneering, Siolta Therapeutics, Finch Therapeutics and more to benchmark your end-to-end microbiome drug strategy with practical industry insights, experiences and lessons learned to help you stay ahead of the curve.
Plus, ensure you're up to date with the latest regulatory guidance and seek out funding opportunities to take your pipeline to the next level.
Like what you just read? You can find similar content on the communities below.
Biopharma Cell Science Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
